RecruitingPhase 2NCT05288790

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT


Sponsor

Vanderbilt University Medical Center

Enrollment

250 participants

Start Date

Sep 18, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Inclusion Criteria1

  • HIV infected

Exclusion Criteria1

  • Not fluent in English

Interventions

DIETARY_SUPPLEMENTProbiotic

Dietary supplement

DIETARY_SUPPLEMENTPlacebo

Placebo sachet


Locations(1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05288790


Related Trials